81 related articles for article (PubMed ID: 11755441)
41. Drug-resistant pathogens in community- and hospital-acquired pneumonia.
Cross JT; Campbell GD
Clin Chest Med; 1999 Sep; 20(3):499-506. PubMed ID: 10516899
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis and treatment of upper respiratory tract infections in the primary care setting.
Fendrick AM; Saint S; Brook I; Jacobs MR; Pelton S; Sethi S
Clin Ther; 2001 Oct; 23(10):1683-706. PubMed ID: 11726004
[TBL] [Abstract][Full Text] [Related]
43. The clinical impact of macrolide resistance in pneumococcal respiratory infections.
Garau J
Int J Antimicrob Agents; 2001; 18 Suppl 1():S33-8. PubMed ID: 11574193
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic implications of antibacterial resistance in community-acquired respiratory tract infections in children.
Cunha BA
Infection; 2004 Apr; 32(2):98-108. PubMed ID: 15057574
[TBL] [Abstract][Full Text] [Related]
45. Amoxicillin/clavulanate potassium extended release tablets: a new antimicrobial for the treatment of acute bacterial sinusitis and community-acquired pneumonia.
Benninger MS
Expert Opin Pharmacother; 2003 Oct; 4(10):1839-46. PubMed ID: 14521493
[TBL] [Abstract][Full Text] [Related]
46. Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines.
Bradley JS
Pediatr Infect Dis J; 2002 Jun; 21(6):592-8; discussion 613-4. PubMed ID: 12182396
[TBL] [Abstract][Full Text] [Related]
47. Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae.
Moellering RC; Craig W; Edmond M; Farrell DJ; Ferraro MJ; File TM; Klein J; Lonks J; Metlay JP; Sahm D; Talbot GH;
J Chemother; 2002 Jul; 14 Suppl 3():42-56. PubMed ID: 12418560
[TBL] [Abstract][Full Text] [Related]
48. Cefditoren in upper and lower community-acquired respiratory tract infections.
Soriano F; Giménez MJ; Aguilar L
Drug Des Devel Ther; 2011 Feb; 5():85-94. PubMed ID: 21340042
[TBL] [Abstract][Full Text] [Related]
49. Acute bronchitis: results of U.S. and European trials of antibiotic therapy.
Dere WH
Am J Med; 1992 Jun; 92(6A):53S-57S. PubMed ID: 1621745
[TBL] [Abstract][Full Text] [Related]
50. Antibiotic resistance and therapeutic options in lower respiratory tract infections.
Bouza E
Int J Antimicrob Agents; 1999 Mar; 11 Suppl 1():S3-6; discussion S31-2. PubMed ID: 10204633
[TBL] [Abstract][Full Text] [Related]
51. Emerging resistance to antibiotics against respiratory bacteria: impact on therapy of community-acquired pneumonia in children.
Esposito S; Principi N
Drug Resist Updat; 2002 Apr; 5(2):73-87. PubMed ID: 12135583
[TBL] [Abstract][Full Text] [Related]
52. Principles of appropriate antibiotic use.
Niederman MS
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 3():S170-5. PubMed ID: 16543079
[TBL] [Abstract][Full Text] [Related]
53. Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance.
Metlay JP; Singer DE
Clin Microbiol Infect; 2002; 8 Suppl 2():1-11. PubMed ID: 12427205
[TBL] [Abstract][Full Text] [Related]
54. Bacterial Community Interactions During Chronic Respiratory Disease.
Welp AL; Bomberger JM
Front Cell Infect Microbiol; 2020; 10():213. PubMed ID: 32477966
[TBL] [Abstract][Full Text] [Related]
55. Current issues on resistance, treatment guidelines, and the appropriate use of fluoroquinolones for respiratory tract infections.
Bishai W
Clin Ther; 2002 Jun; 24(6):838-50; discussion 837. PubMed ID: 12117077
[TBL] [Abstract][Full Text] [Related]
56. Role of oral antibiotics in treatment of community-acquired lower respiratory tract infections.
Legnani D
Diagn Microbiol Infect Dis; 1997; 27(1-2):41-7. PubMed ID: 9127105
[TBL] [Abstract][Full Text] [Related]
57. Susceptibility of community-acquired pathogens to antibiotics in Africa and Asia in neonates--an alarmingly short review.
Lubell Y; Ashley EA; Turner C; Turner P; White NJ
Trop Med Int Health; 2011 Feb; 16(2):145-51. PubMed ID: 21078009
[TBL] [Abstract][Full Text] [Related]
58. Macrolide-resistant Streptococcus pneumoniae: clinical implications for the empiric treatment of community-acquired respiratory tract infections.
Brunton S; Iannini P
MedGenMed; 2005 Dec; 7(4):63. PubMed ID: 16614685
[No Abstract] [Full Text] [Related]
59. Social-economic factors and irrational antibiotic use as reasons for antibiotic resistance of bacteria causing common childhood infections in primary healthcare.
Ilić K; Jakovljević E; Skodrić-Trifunović V
Eur J Pediatr; 2012 May; 171(5):767-77. PubMed ID: 21987082
[TBL] [Abstract][Full Text] [Related]
60. Antimicrobial Resistance and Respiratory Infections.
Guitor AK; Wright GD
Chest; 2018 Nov; 154(5):1202-1212. PubMed ID: 29959904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
